Marschall S Runge

LLY

Marschall S Runge serves as Director at Eli Lilly and Company (LLY). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$49.8K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$49.8K

Companies Traded

LLY

Active Period

Mar 2022

1 total trades

Most Recent

Buy LLY

Mar 7, 2022 · $49.8K

Marschall S Runge's Insider Trading at Eli Lilly and Company (LLY)

Buys

1 · $49.8K

Sells

0 · $0.00

Total Shares Bought

202

Total Shares Sold

LLY Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 7, 2022	Buy	202	$246.78	$49.8K	15,436

Related Insiders

Adrienne S Brown

EVP, President LLY Imm

LLYSell · Feb 18, 2026

Kenneth L. Custer

EVP & President, Card Met Hlth

LLYSell · Feb 16, 2026

Lucas Montarce

EVP & CFO

LLYSell · Feb 16, 2026

Donald A Zakrowski

SVP, Finance, & CAO

LLYSell · Feb 16, 2026

Edgardo Hernandez

EVP & Pres., Mfg. Operations

LLYSell · Feb 3, 2026

Patrik Jonsson

EVP & President, LLY Int'l

LLYSell · Feb 3, 2026

Anat Hakim

EVP, GC & Secretary

LLYSell · Feb 3, 2026

Eric Dozier

EVP, Chief People Officer

LLYSell · Feb 3, 2026

Explore More Insider Trading Data

LLY Insider Trading Activity

View all insider trades at Eli Lilly and Company

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity